Parkwood LLC’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-49,730
Closed -$4.53M 76
2019
Q1
$4.53M Buy
+49,730
New +$4.45M 0.89% 43
2018
Q4
Sell
-57,051
Closed -$5.61M 79
2018
Q3
$5.61M Buy
+57,051
New +$5.27M 0.95% 34
2017
Q4
Sell
-38,458
Closed -$2.99M 252
2017
Q3
$2.99M Buy
38,458
+34,971
+1,003% +$2.9M 0.45% 55
2017
Q2
$309K Sell
3,487
-692
-17% -$58.4K 0.05% 286
2017
Q1
$337K Sell
4,179
-3,992
-49% -$312K 0.05% 246
2016
Q4
$582K Sell
8,171
-9,184
-53% -$722K 0.09% 159
2016
Q3
$1.5M Buy
+17,355
New +$1.51M 0.22% 96
2015
Q3
Sell
-6,655
Closed -$493K 533
2015
Q2
$493K Buy
+6,655
New +$508K 0.07% 191
2014
Q1
Sell
-5,203
Closed -$299K 333
2013
Q4
$299K Buy
+5,203
New +$295K 0.08% 96

Other funds holding MDT

Parkwood LLC's MDT Position: Q2 2019 in Review

Parkwood LLC sold out of Medtronic (MDT) in Q2 2019, closing a stake of 49,730 shares — an estimated $4.53M sold.

Parkwood LLC first reported a position in MDT in Q4 2013 and held it in 9 quarters. The position peaked at $5.61M in Q3 2018. 1,619 funds tracked by Wall St. Rank hold MDT as of Q2 2019.

  • Parkwood LLC reported no remaining Medtronic position as of Q2 2019 after selling out during the quarter.
  • Parkwood LLC sold 49,730 Medtronic shares in Q2 2019, an estimated $4.53M.
  • Parkwood LLC first reported a position in Medtronic in Q4 2013 and held it in 9 quarters.
  • Parkwood LLC's Medtronic position peaked at $5.61M in Q3 2018.
  • 1,619 funds tracked by Wall St. Rank held Medtronic as of Q2 2019.

Based on Parkwood LLC's 13F filing for Q2 2019, filed 8 Aug 2019.